Skip to main content

Showing 1–3 of 3 results for author: Rundo, M

Searching in archive eess. Search in all archives.
.
  1. arXiv:2308.03770  [pdf, other

    cs.CV cs.AI eess.IV

    Visual Saliency Detection in Advanced Driver Assistance Systems

    Authors: Francesco Rundo, Michael Sebastian Rundo, Concetto Spampinato

    Abstract: Visual Saliency refers to the innate human mechanism of focusing on and extracting important features from the observed environment. Recently, there has been a notable surge of interest in the field of automotive research regarding the estimation of visual saliency. While operating a vehicle, drivers naturally direct their attention towards specific objects, employing brain-driven saliency mechani… ▽ More

    Submitted 26 July, 2023; originally announced August 2023.

  2. arXiv:2308.02415  [pdf, other

    eess.SP cs.AI

    Car-Driver Drowsiness Assessment through 1D Temporal Convolutional Networks

    Authors: Francesco Rundo, Concetto Spampinato, Michael Rundo

    Abstract: Recently, the scientific progress of Advanced Driver Assistance System solutions (ADAS) has played a key role in enhancing the overall safety of driving. ADAS technology enables active control of vehicles to prevent potentially risky situations. An important aspect that researchers have focused on is the analysis of the driver attention level, as recent reports confirmed a rising number of acciden… ▽ More

    Submitted 27 July, 2023; originally announced August 2023.

  3. arXiv:2307.14398  [pdf, other

    eess.IV cs.AI

    Non-Linear Self Augmentation Deep Pipeline for Cancer Treatment outcome Prediction

    Authors: Francesco Rundo, Concetto Spampinato, Michael Rundo

    Abstract: Immunotherapy emerges as promising approach for treating cancer. Encouraging findings have validated the efficacy of immunotherapy medications in addressing tumors, resulting in prolonged survival rates and notable reductions in toxicity compared to conventional chemotherapy methods. However, the pool of eligible patients for immunotherapy remains relatively small, indicating a lack of comprehensi… ▽ More

    Submitted 26 July, 2023; originally announced July 2023.